Short-term outcomes in patients with center-involving diabetic macular edema after a single dose of intravitreal bevacizumab

被引:0
|
作者
Christopher A. Turski
Mitchell A. Jacobs
Michelle M. Abou-Jaoude
Nicholas H. Fowler
Ryan Harpole
Emily Altman
John B. Chadwell
Gabriel Kindl
Hayley R. James
Shivani V. Reddy
Ramiro S. Maldonado
机构
[1] University of Kentucky,Department of Ophthalmology
[2] Duke University Eye Center,Department of Ophthalmology
关键词
Anti-VEGF; Bevacizumab; Center-involving diabetic macular edema; Central subfield thickness; Responders; Non-responders; Subretinal fluid;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [31] Quantitative evaluation of hard exudates in diabetic macular edema after short-term intravitreal triamcinolone, dexamethasone implant or bevacizumab injections
    Shin, Yong Un
    Hong, Eun Hee
    Lim, Han Woong
    Kang, Min Ho
    Seong, Mincheol
    Cho, Heeyoon
    BMC OPHTHALMOLOGY, 2017, 17
  • [32] The Short-Term Efficacy of Biweekly Subconjunctival Bevacizumab in Diabetic Macular Edema
    Yeter, Volkan
    Yucel, Ozlem Eski
    Birinci, Hakke
    CURRENT EYE RESEARCH, 2020, 45 (05) : 585 - 590
  • [33] Baseline Subfoveal Choroidal Thickness as a Predictor for Response to Short-Term Intravitreal Bevacizumab Injections in Diabetic Macular Edema
    Dweikat, Alaa
    Jarrar, Arkan
    Akkawi, Mohammad
    Shehadeh, Mohammad
    Aghbar, Ammar
    Qaddumi, Jamal
    Akkawi, Maha
    CLINICAL OPHTHALMOLOGY, 2021, 15 : 4175 - 4180
  • [34] Short-term efficacy of intravitreal bevacizumab for the treatment of macular edema due to diabetic retinopathy and retinal vein occlusion
    Astam N.
    Batioǧlu F.
    Özmert E.
    International Ophthalmology, 2009, 29 (5) : 343 - 348
  • [35] Short-term effect on intraocular pressure after intravitreal aflibercept injection for diabetic macular edema
    Alshehri, Tariq S.
    Alshehri, Afnan A.
    Hassan, Ahmed
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2017, 58 (08)
  • [36] Evaluation of short-term intraocular pressure changes after intravitreal injection of Conbercept in patients with diabetic macular edema
    Hu, Yunyan
    Zeng, Yunkao
    Yang, Jing
    Zeng, Xiaomin
    Cao, Dan
    Ou, Biqun
    Zhang, Guanrong
    Zhang, Liang
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [37] Guidelines for the Management of Center-Involving Diabetic Macular Edema: Treatment Options and Patient Monitorization
    Figueira, Joao
    Henriques, Jose
    Carneiro, Angela
    Marques-Neves, Carlos
    Flores, Rita
    Meireles, Joao Paulo Castro-Sousa - Angelina
    Meireles, Angelina
    Gomes, Nuno
    Nascimento, Joao
    Amaro, Miguel
    Silva, Rufino
    CLINICAL OPHTHALMOLOGY, 2021, 15 : 3221 - 3230
  • [38] Short-term effect of intravitreal dexamethasone implant in refractory diabetic macular edema
    Jazmín Baca Moreno
    David Berrones Medina
    María Fernanda Rosellón-Escobar
    José Gerardo García-Aguirre
    BMC Ophthalmology, 24
  • [39] Short-term effect of intravitreal dexamethasone implant in refractory diabetic macular edema
    Moreno, Jazmin Baca
    Medina, David Berrones
    Rosellon-Escobar, Maria Fernanda
    Garcia-Aguirre, Jose Gerardo
    BMC OPHTHALMOLOGY, 2024, 24 (01)
  • [40] Letter to the Editor: Short-Term Outcomes of Aflibercept Therapy for Diabetic Macular Edema in Patients With Incomplete Response to Ranibizumab and/or Bevacizumab
    Calugaru, Dan
    Calugaru, Mihai
    OPHTHALMIC SURGERY LASERS & IMAGING RETINA, 2017, 48 (04): : 280 - 280